These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 24218136)

  • 1. Selective MAO-B inhibitors: a lesson from natural products.
    Carradori S; D'Ascenzio M; Chimenti P; Secci D; Bolasco A
    Mol Divers; 2014 Feb; 18(1):219-43. PubMed ID: 24218136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human monoamine oxidase A and B by flavonoids isolated from two Algerian medicinal plants.
    Larit F; Elokely KM; Chaurasiya ND; Benyahia S; Nael MA; León F; Abu-Darwish MS; Efferth T; Wang YH; Belouahem-Abed D; Benayache S; Tekwani BL; Cutler SJ
    Phytomedicine; 2018 Feb; 40():27-36. PubMed ID: 29496172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine oxidase B inhibitors based on natural privileged scaffolds: A review of systematically structural modification.
    Lv Y; Zheng Z; Liu R; Guo J; Zhang C; Xie Y
    Int J Biol Macromol; 2023 Nov; 251():126158. PubMed ID: 37549764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positional scanning of natural product hispidol's ring-B: discovery of highly selective human monoamine oxidase-B inhibitor analogues downregulating neuroinflammation for management of neurodegenerative diseases.
    Hassan AHE; Kim HJ; Gee MS; Park JH; Jeon HR; Lee CJ; Choi Y; Moon S; Lee D; Lee JK; Park KD; Lee YS
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):768-780. PubMed ID: 35196956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural Products as Monoamine Oxidase Inhibitors: Potential Agents for Neurological Disorders.
    Agrawal N; Bhardwaj A; Singh S; Goyal A; Gaurav A
    Comb Chem High Throughput Screen; 2024; 27(5):701-714. PubMed ID: 37165491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advancements and SAR Studies of Synthetic Coumarins as MAO-B Inhibitors: An Updated Review.
    Kaur P; Rangra NK
    Mini Rev Med Chem; 2024; 24(20):1834-1846. PubMed ID: 38778598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Selected Natural Compounds as Dual Inhibitors of Catechol-O-Methyltransferase and Monoamine Oxidase.
    Engelbrecht I; Petzer JP; Petzer A
    Cent Nerv Syst Agents Med Chem; 2019; 19(2):133-145. PubMed ID: 31258092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comprehensive Review of Monoamine Oxidase-A Inhibitors in their Syntheses and Potencies.
    Rehuman NA; Mathew B; Jat RK; Nicolotti O; Kim H
    Comb Chem High Throughput Screen; 2020; 23(9):898-914. PubMed ID: 32342809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine oxidase and neurodegeneration: Mechanisms, inhibitors and natural compounds for therapeutic intervention.
    Banerjee C; Tripathy D; Kumar D; Chakraborty J
    Neurochem Int; 2024 Oct; 179():105831. PubMed ID: 39128624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docking-Related Survey on Natural-Product-Based New Monoamine Oxidase Inhibitors and Their Therapeutic Potential.
    Dhiman P; Malik N; Khatkar A
    Comb Chem High Throughput Screen; 2017; 20(6):474-491. PubMed ID: 28413973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinolinyl-thienyl chalcones as monoamine oxidase inhibitors and their in silico modeling studies.
    Zaib S; Rizvi SU; Aslam S; Ahmad M; Ali Abid SM; Al-Rashida M; Iqbal J
    Med Chem; 2015; 11(6):580-9. PubMed ID: 25541744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Interactions of
    Chaurasiya ND; Midiwo J; Pandey P; Bwire RN; Doerksen RJ; Muhammad I; Tekwani BL
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33212830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Privileged scaffolds as MAO inhibitors: Retrospect and prospects.
    Tripathi AC; Upadhyay S; Paliwal S; Saraf SK
    Eur J Med Chem; 2018 Feb; 145():445-497. PubMed ID: 29335210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benextramine and derivatives as novel human monoamine oxidases inhibitors: an integrated approach.
    Di Paolo ML; Cozza G; Milelli A; Zonta F; Sarno S; Minniti E; Ursini F; Rosini M; Minarini A
    FEBS J; 2019 Dec; 286(24):4995-5015. PubMed ID: 31291696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel reversible monoamine oxidase A inhibitors: highly potent and selective 3-(1H-pyrrol-3-yl)-2-oxazolidinones.
    Valente S; Tomassi S; Tempera G; Saccoccio S; Agostinelli E; Mai A
    J Med Chem; 2011 Dec; 54(23):8228-32. PubMed ID: 22017497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel monoamine oxidase selective inhibitors employing a hierarchical ligand-based virtual screening strategy.
    Wang D; Li Z; Liu Y; Chen M; Chen N; Zuo Z; Kong DX
    Future Med Chem; 2019 Apr; 11(8):801-816. PubMed ID: 31140884
    [No Abstract]   [Full Text] [Related]  

  • 17. A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer's disease agents: A review.
    Manzoor S; Hoda N
    Eur J Med Chem; 2020 Nov; 206():112787. PubMed ID: 32942081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine Oxidase Inhibitors: From Classic to New Clinical Approaches.
    Duarte P; Cuadrado A; León R
    Handb Exp Pharmacol; 2021; 264():229-259. PubMed ID: 32852645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of 1,4-benzoquinones as inhibitors of human monoamine oxidase.
    Mostert S; Petzer A; Petzer JP
    Eur J Med Chem; 2017 Jul; 135():196-203. PubMed ID: 28456030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plant secondary metabolites- potent inhibitors of monoamine oxidase isoforms.
    Mathew B; Suresh J; Mathew GE; Parasuraman R; Abdulla N
    Cent Nerv Syst Agents Med Chem; 2014; 14(1):28-33. PubMed ID: 25142815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.